Published in BMB Rep on March 01, 2015
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea (2006) 3.18
Protein transduction technology. Curr Opin Biotechnol (2002) 2.90
Hormone replacement therapy and dry eye syndrome. JAMA (2001) 2.46
A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci (2002) 1.73
Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Biochem J (1996) 1.54
Injury to the eye. BMJ (2004) 1.45
Epidemiology of dry eye syndrome. Adv Exp Med Biol (2002) 1.43
Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci (2001) 1.38
Immunophilins: switched on protein binding domains? Med Res Rev (2000) 1.29
TAT-mediated PRDX6 protein transduction protects against eye lens epithelial cell death and delays lens opacity. Am J Physiol Cell Physiol (2008) 1.27
Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells. Cell Death Differ (2010) 1.26
Tear evaporimeter for measuring water evaporation rate from the tear film under controlled conditions in humans. Exp Eye Res (1983) 1.20
Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis. Exp Eye Res (2009) 1.17
A murine model of dry eye induced by an intelligently controlled environmental system. Invest Ophthalmol Vis Sci (2008) 1.16
Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv (2007) 1.12
Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H(2)O(2) injury. J Neurochem (2002) 1.06
Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys. Arch Ophthalmol (2000) 1.01
A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents. Med Hypotheses (2006) 1.00
Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research. Curr Pharm Biotechnol (2010) 0.99
Protective effect of D-beta-hydroxybutyrate on corneal epithelia in dry eye conditions through suppression of apoptosis. Invest Ophthalmol Vis Sci (2003) 0.98
Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice. J Invest Dermatol (2011) 0.94
D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board. Invest Ophthalmol Vis Sci (2005) 0.94
Transduced PEP-1-FK506BP inhibits the inflammatory response in the Raw 264.7 cell and mouse models. Immunobiology (2010) 0.91
Diagnosing dry eye using a blue-free barrier filter. Am J Ophthalmol (2003) 0.90
Tat-glyoxalase protein inhibits against ischemic neuronal cell damage and ameliorates ischemic injury. Free Radic Biol Med (2013) 0.88
Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations. Cornea (2004) 0.88
Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Toxicology (2010) 0.88
Albumin rescues ocular epithelial cells from cell death in dry eye. Curr Eye Res (2007) 0.88
Anti-inflammatory effect of transduced PEP-1-heme oxygenase-1 in Raw 264.7 cells and a mouse edema model. Biochem Biophys Res Commun (2011) 0.86
Transduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse model. BMB Rep (2013) 0.86
PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model. Free Radic Biol Med (2012) 0.85
The therapeutic and diagnostic potential of FKBPL; a novel anticancer protein. Drug Discov Today (2012) 0.84
Protective effects of skin permeable epidermal and fibroblast growth factor against ultraviolet-induced skin damage and human skin wrinkles. J Cosmet Dermatol (2013) 0.82
Transduced protein transduction domain linked HSP27 protected LECs against UVB radiation-induced damage. Exp Eye Res (2014) 0.81
Recombinant PTD-Cu/Zn SOD attenuates hypoxia-reoxygenation injury in cardiomyocytes. Free Radic Res (2013) 0.81
Indoor-air quality and ocular discomfort. J Am Optom Assoc (1999) 0.81
Neuroprotective effect of TAT PTD-Ngb fusion protein on primary cortical neurons against hypoxia-induced apoptosis. Neurol Sci (2013) 0.80
Adaptation of the tear film to work in air-conditioned rooms (office-eye syndrome). Ger J Ophthalmol (1994) 0.80
A recombinant trans-membrane protein hMnSOD-R9 inhibits the proliferation of cervical cancer cells in vitro. Mol Cell Biochem (2014) 0.79
Differential expression of the metastasis suppressor KAI1 in decidual cells and trophoblast giant cells at the feto-maternal interface. BMB Rep (2013) 0.78
Bioavailability of fluorescein from a new drug delivery system in human eyes. Br J Ophthalmol (2004) 0.77
Novel immunotherapeutic approaches to skin cancer treatments using protein transduction technology. J Dermatol Sci (2010) 0.77